Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Xavier Castells Olivera

17PUBLICATIONS
53CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersEnvironmental epidemiologyOccupational epidemiologySocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Apr 30, 2026
"Unanswered questions": Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study.

|Jan 30, 2026
Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening.

Uri Ladabaum, Rebeca Font Marimon, Xavier Castells

|Mar 08, 2024
Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.

Carme Miret, Miren Orive, Maria Sala

|Feb 27, 2024
Urinary incontinence in health workers as a predisposing factor for presenteeism in Chile: A mixed-methods exploratory study.

Julieta Aránguiz-Ramírez, Pedro Olivares-Tirado, Cecilia Baeza-Correa

|Jan 29, 2024
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain.

Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro

|Jan 11, 2023
Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.

Carme Miret, Miren Orive, Maria Sala

Pageof 3

Frequent Collaborators

5 joint publications

Maximino Redondo

5 joint publications

María Sala

4 joint publications

Javier Louro

3 joint publications

Laia Domingo

3 joint publications

Marta Román

3 joint publications

Susana García-Gutiérrez

3 joint publications

Amado Rivero

3 joint publications

José María Quintana

2 joint publications

María Padilla-Ruiz

2 joint publications

Francisco Rivas-Ruiz

Frequent Collaborators

5 joint publications

Maximino Redondo

5 joint publications

María Sala

4 joint publications

Javier Louro

3 joint publications

Laia Domingo

Top Related Videos

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

6.0K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on : Jun 08, 2020

7.4K
See more related videos

Top Related Videos

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

6.0K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on : Jun 08, 2020

7.4K
See more related videos